Proton Beam Therapy — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Lower exit and integral normal-tissue dose can improve the high-dose therapeutic ratio
The relevant advantage is dose distribution: proton range and rapid distal fall-off can reduce dose beyond the target and lower integral normal-tissue exposure when high-dose treatment lies beside critical structures. Protons still have entrance dose, range uncertainty and full planning requirements; their clinical RBE is not several-fold higher, and NHS England explicitly notes that they are not superior for most cancers. The decision therefore rests on a specialist comparative plan and therapeutic ratio, not a universal claim.
Reference: NHS England: proton beam therapy commissioning information (Current NHS England information, accessed August 2026): https://www.england.nhs.uk/commissioning/spec-services/highly-spec-services/pbt/